BCR and neoplasm: In addition, we also found that the MYC signaling activation group also showed higher intratumoral heterogeneity, IFN-gamma response and M1/M2 macrophages and lower TCR shannon, while the tumor purity and BCR shannon did not be significantly different between the two groups (Figure 4A).